Class information for:
Level 1: STAVANGER NEUROL UNIT//10 11 EPOXIDE//A1298C MUTATION

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
23028 305 32.4 59%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
46 30816 EPILEPSY//EPILEPSIA//ANTIEPILEPTIC DRUGS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 STAVANGER NEUROL UNIT Address 2 50% 1% 3
2 10 11 EPOXIDE Author keyword 1 50% 0% 1
3 A1298C MUTATION Author keyword 1 50% 0% 1
4 ALLAN BETTY TAYLOR LIB Address 1 50% 0% 1
5 CARBAMAZEPINE MONOTHERAPY Author keyword 1 50% 0% 1
6 DG DGGE Author keyword 1 50% 0% 1
7 DIPARTIMENTO SCI BIOMED IMMAGINI MORFOL FUNZI Address 1 50% 0% 1
8 DPT NEUROSCI Address 1 50% 0% 1
9 INTERNAL MED RHEMATOL Address 1 50% 0% 1
10 PHARMACOL CLIN UNIT Address 1 50% 0% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 10 11 EPOXIDE 1 50% 0% 1 Search 10+11+EPOXIDE Search 10+11+EPOXIDE
2 A1298C MUTATION 1 50% 0% 1 Search A1298C+MUTATION Search A1298C+MUTATION
3 CARBAMAZEPINE MONOTHERAPY 1 50% 0% 1 Search CARBAMAZEPINE+MONOTHERAPY Search CARBAMAZEPINE+MONOTHERAPY
4 DG DGGE 1 50% 0% 1 Search DG+DGGE Search DG+DGGE
5 SERUM LIPOPROTEIN A 1 50% 0% 1 Search SERUM+LIPOPROTEIN+A Search SERUM+LIPOPROTEIN+A
6 PATIENTS WITH EPILEPSY 1 25% 1% 2 Search PATIENTS+WITH+EPILEPSY Search PATIENTS+WITH+EPILEPSY
7 METHIONINE LOADING 0 14% 1% 3 Search METHIONINE+LOADING Search METHIONINE+LOADING
8 ATHEROSCLEROTIC MARKERS 0 33% 0% 1 Search ATHEROSCLEROTIC+MARKERS Search ATHEROSCLEROTIC+MARKERS
9 C677T MTHFR POLYMORPHISM 0 33% 0% 1 Search C677T+MTHFR+POLYMORPHISM Search C677T+MTHFR+POLYMORPHISM
10 ENDOGENOUS PATHWAYS 0 33% 0% 1 Search ENDOGENOUS+PATHWAYS Search ENDOGENOUS+PATHWAYS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 TERM ANTICONVULSIVE TREATMENT 14 100% 2% 7
2 ANTICONVULSIVE TREATMENT 9 83% 2% 5
3 CHRONIC PHENYTOIN TREATMENT 4 75% 1% 3
4 ELEVATED PLASMA CONCENTRATIONS 4 75% 1% 3
5 MICROSOMAL ENZYME INDUCTION 3 26% 3% 10
6 APOLIPOPROTEIN A 3 25% 3% 10
7 ANTIEPILEPTIC DRUG MONOTHERAPY 3 26% 3% 9
8 PHENYTOIN TREATMENT 3 42% 2% 5
9 EPILEPTIC CHILDREN 2 13% 5% 14
10 LONG TERM CARBAMAZEPINE 1 100% 1% 2

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Antiepileptic Drugs and Markers of Vascular Risk 2010 22 51 65%
Serum Level of Homocysteine, Folate and Vitamin-B12 in Epileptic Patients Under Carbamazepine and Sodium Valproate Treatment: A Systematic Review and Meta-Analysis 2013 5 18 89%
Enzyme induction with antiepileptic drugs: Cause for concern? 2013 35 161 16%
Evaluation of the relationship between C677T variants of methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in children receiving antiepileptic drug therapy 2008 11 27 48%
Antiepileptic drugs, hyperhomocysteinemia and B-vitamins supplementation in patients with epilepsy 2012 12 65 43%
Atherosclerotic risk among children taking antiepileptic drugs 2009 16 110 40%
Antiepileptic drug use for treatment of epilepsy and dyslipidemia: Systematic review 2015 0 48 58%
MICROSOMAL-ENZYME INDUCTION, LIPOPROTEINS AND ATHEROSCLEROSIS 1988 40 21 67%
Association between methylenetetrahydrofolate reductase C677T polymorphism and epilepsy susceptibility: A meta-analysis 2014 1 43 21%
Elimination of endoplasmic reticulum stress and cardiovascular, type 2 diabetic, and other metabolic diseases 2013 5 100 17%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 STAVANGER NEUROL UNIT 2 50% 1.0% 3
2 ALLAN BETTY TAYLOR LIB 1 50% 0.3% 1
3 DIPARTIMENTO SCI BIOMED IMMAGINI MORFOL FUNZI 1 50% 0.3% 1
4 DPT NEUROSCI 1 50% 0.3% 1
5 INTERNAL MED RHEMATOL 1 50% 0.3% 1
6 PHARMACOL CLIN UNIT 1 50% 0.3% 1
7 REG EPILEPSY CHAIR CLIN NEUROPHYSIOL 1 50% 0.3% 1
8 SAMSUNG BIOMED KANGNAM KU 1 50% 0.3% 1
9 SERV NUTR CRECIMIENTO DESARROLLO 1 50% 0.3% 1
10 CIENCIAS SALUD PSICOL CLIN 0 33% 0.3% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000225799 HARVARD NEUROENDOCRINE UNIT//CATAMENIAL EPILEPSY//HYPOSEXUALITY
2 0.0000135904 BILATERAL FEMORAL NECK FRACTURE//CLIN DENT DISABLED//ELECT SERV ENGN
3 0.0000091078 SUDEP//SUDDEN UNEXPECTED DEATH IN EPILEPSY//ICTAL ASYSTOLE
4 0.0000089781 EXPT NEUROCHEM//DL HOMOCYSTEIC ACID INDUCED SEIZURES//ANTIEPILEPT OUTPATIENT CLIN
5 0.0000086083 EMORY EPILEPSY PROGRAM//KERALA REGISTRY EPILEPSY PREGNANCY//FETAL HYDANTOIN SYNDROME
6 0.0000085870 CELLULAR NEUROBIOL NEURODEGENERAT//PSYCHOGERIATRIC PATIENTS//STUDY PHYSIOPATHOL AGING
7 0.0000073008 REVUE DE L ALCOOLISME//CHOLESTEROL FRACTION//DILINOLEOYL PHOSPHATIDYLCHOLINE
8 0.0000070615 AUDITORY DISTURBANCE//PERIPHERAL NEUROMUSCULAR FUNCTION//ACUTE FORM
9 0.0000065220 LATE ONSET SEIZURES//STROKE RELATED SEIZURES//POST STROKE EPILEPSY
10 0.0000054568 ASAN FDN//DA 125//MED DIAGNOST PATHOL